A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 45 (2) , 187-195
- https://doi.org/10.1067/mjd.2001.115965
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoinJournal of the American Academy of Dermatology, 2001
- Isotretinoin – An Explanation for Its Long-Term BenefitDermatology, 1987
- Isotretinoin therapy for acne: Results of a multicenter dose-response studyJournal of the American Academy of Dermatology, 1984
- Food Increases the Bioavailability of IsotretinoinThe Journal of Clinical Pharmacology, 1983
- Isotretinoin versus placebo in the treatment of cystic acneJournal of the American Academy of Dermatology, 1982
- The treatment of severe cystic acne with 13-cis-retinoic acidJournal of the American Academy of Dermatology, 1980
- 13-CIS RETINOIC ACID AND ACNEThe Lancet, 1980
- Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic AcidNew England Journal of Medicine, 1979